Significantly greater cancer detection rates were noted by all three readers for comparisons of gadobenate dimeglumine-enhanced MRI with mammography ( @ % ; P < @ ) , ultrasound ( @ % ; P < @ ) , and mammography and/or ultrasound ( @ % ; P @ ) but not for comparisons of gadopentetate dimeglumine-enhanced MRI with conventional techniques ( P > @ ) .